LOGISTICS GIANT DELIVERS IN SYDNEY
Port Botany, one of Sydney’s largest container ports, is due for a A$400 million rail terminal extension thanks to a new co-investment project announced between DP World and NSW Ports. The new facility constructed by the duo will support the port’s Container Terminal and Logistics Park, including five new rail sidings to accommodate 600-meter-long regional trains. “Our investment in this new port-centric logistics infrastructure will deliver more capacity, superior agility, seamless integration of processes, increased productivity and added reliability,” said DP World Oceania Executive Vice President Nicolaj Noes. “We cannot wait for our present and future customers to reap the benefits of this world-class facility, which accelerates the shift of freight from road to rail while reducing carbon emissions and improving Sydney’s air quality at the same time.” The 20-acre Sydney Logistics Park, operated by DP World, will be able to double its annual rail capacity to 1 million twenty-foot equivalent units once complete in 2027.
Getty Images
DOMESTIC BIOMANUFACTURING BOOST IN ALBERTA
Canada-based Entos Pharmaceuticals has gained over C$54 million in funding support from the Government of Canada and Government of Alberta to move forward on its new C$137.2 million biomanufacturing facility investment. The planned 103,000-sq.-ft. plant will be located in Alberta’s capital city of Edmonton, aiming to foster R&D collaboration among the company, local academic institutions and industry partners. As the company was created out of the University of Alberta, the project builds upon the region’s thriving industry ecosystem. “We are thrilled to receive this investment, which will enable us to build a cutting-edge GMP biomanufacturing facility and innovative R&D center,” said Entos Pharmaceuticals CEO John Lewis. “It will help us develop, scale up, produce and commercialize Fusogenix PLV therapeutics to address critical health needs and fill gaps in Canada’s domestic manufacturing capacity.” Once operational the manufacturing facility will develop and produce the company’s Fusogenix PLV drug delivery platform and the next generation of medicines.
Photo courtesy of SAIL
STEEL EXPANSION SETS SAIL IN ODISHA
The Steel Authority of India Limited (SAIL) plans to grow its 66-year-old Rourkela Steel Plant in India’s eastern state of Odisha. Last week it was announced that the company would invest $3.45 billion to expand production capabilities at the 1,200-acre site, growing from its current 4.4 million metric tons per year to 9 million metric tons. Project details include a new raw material handling plant, a coke oven stamp charge battery, a sinter plant, thin slab caster direct rolling, a cold rolling mill and a silicon rolling mill. Once complete, SAIL has noted that this manufacturing location will account for 25% of the company’s total steel output, which is said to be 35 million metric tons annually by 2030.
Reports compiled and written by Alexis Elmore
